Published: February 09, 2005

OR-Live.com Presents: Endovascular Abdominal Aortic Aneurysm Repair With the GORE EXCLUDER(R) Bifurcated Endoprosthesis

Share This Story

Live Webcast: Tuesday, March 15, 2005 at 2 pm EST

Surgeons from Surgical Care Associates, Louisville, Kentucky, will perform an endovascular abdominal aortic aneurysm repair with the GORE EXCLUDER® Bifurcated Endoprosthesis in a live webcast on www.OR-Live.com. The procedure will be performed at Baptist Hospital East in Louisville, Kentucky.

The annual mortality from abdominal aortic aneurysms (AAA) rupture is 15,000 patients, making it the 13th leading cause of death in the U.S. Traditional surgical treatment of AAA involves a large incision to place a synthetic graft to repair the diseased artery. This method can result in long hospital stays and painful recoveries. Physicians continue to seek less invasive alternatives to this major open surgical approach.

Gore's EXCLUDER® Bifurcated Endoprosthesis is an innovative device designed to be a minimally invasive treatment option for patients with abdominal aortic aneurysms (AAA). It is constructed of a durable ePTFE bifurcated graft with an outer self-expanding Nitinol support structure to combine both device flexibility and material durability. The function of the endoprosthesis is to internally reline the abdominal aorta, including the bifurcation, and isolate the aneurysm. The device is inserted by a catheter-based delivery technique through small incisions in the patient's legs. The expected outcomes of this new treatment option include decreased procedural times and shorter hospital stays.

20,000 GORE EXCLUDER® Devices have been distributed worldwide through January 2005. At four years, the Pivotal Trial investigative sites have reported:

-- 0 ruptures

-- 0 post-procedure migrations of any component

-- 0 stent fractures

-- 0 graft tears

-- 0 post-operative limb disconnections

-- 10% total endoleak rate (1% Type I, 7% Type II, 0% Type III and IV, and 2% Indeterminate)

-- 100% cumulative patency

-- Low post-procedure conversion rate of 3.8%

Visit http://www.or-live.com/gore/1312 now to learn more and view a program preview. A VNR is available at http://www.or-live.com/rams/wlg-1312-mkw-q.ram

GORE and EXCLUDER® are trademarks of W. L. Gore & Associates.

Distributed by Market Wire